Literature DB >> 18048491

Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations.

Florian W Kiefer1, Maximilian Zeyda, Jelena Todoric, Joakim Huber, René Geyeregger, Thomas Weichhart, Oskar Aszmann, Bernhard Ludvik, Gerd R Silberhumer, Gerhard Prager, Thomas M Stulnig.   

Abstract

Obesity is associated with a chronic low-grade inflammation characterized by macrophage infiltration of adipose tissue (AT) that may underlie the development of insulin resistance and type 2 diabetes. Osteopontin (OPN) is a multifunctional protein involved in various inflammatory processes, cell migration, and tissue remodeling. Because these processes occur in the AT of obese patients, we studied in detail the regulation of OPN expression in human and murine obesity. The study included 20 morbidly obese patients and 20 age- and sex-matched control subjects, as well as two models (diet-induced and genetic) of murine obesity. In high-fat diet-induced and genetically obese mice, OPN expression was drastically up-regulated in AT (40 and 80-fold, respectively) but remained largely unaltered in liver (<2-fold). Moreover, OPN plasma concentrations remained unchanged in both murine models of obesity, suggesting a particular local but not systemic importance for OPN. OPN expression was strongly elevated also in the AT of obese patients compared with lean subjects in both omental and sc AT. In addition, we detected three OPN isoforms to be expressed in human AT and, strikingly, an obesity induced alteration of the OPN isoform expression pattern. Analysis of AT cellular fractions revealed that OPN is exceptionally highly expressed in AT macrophages in humans and mice. Moreover, OPN expression in AT macrophages was strongly up-regulated by obesity. In conclusion, our data point toward a specific local role of OPN in obese AT. Therefore, OPN could be a critical regulator in obesity induced AT inflammation and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048491     DOI: 10.1210/en.2007-1312

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  56 in total

Review 1.  The obesity of bone.

Authors:  Emanuela A Greco; Andrea Lenzi; Silvia Migliaccio
Journal:  Ther Adv Endocrinol Metab       Date:  2015-12       Impact factor: 3.565

2.  Effect of sleeve gastrectomy on osteopontin circulating levels and expression in adipose tissue and liver in rats.

Authors:  Andoni Lancha; Rafael Moncada; Víctor Valentí; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Leire Méndez-Giménez; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

3.  Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis.

Authors:  Hye-In Ji; Sang-Hoon Lee; Ran Song; Hyung-In Yang; Yeon-Ah Lee; Seung-Jae Hong; Somi Kim; Yong-Beom Park; Soo-Kon Lee; Myung Chul Yoo; Kyoung Soo Kim
Journal:  Clin Rheumatol       Date:  2013-09-01       Impact factor: 2.980

4.  CD44 contributes to hyaluronan-mediated insulin resistance in skeletal muscle of high-fat-fed C57BL/6 mice.

Authors:  Annie Hasib; Chandani K Hennayake; Deanna P Bracy; Aimée R Bugler-Lamb; Louise Lantier; Faisel Khan; Michael L J Ashford; Rory J McCrimmon; David H Wasserman; Li Kang
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-24       Impact factor: 4.310

Review 5.  The bone-adipose axis in obesity and weight loss.

Authors:  J Gómez-Ambrosi; A Rodríguez; V Catalán; G Frühbeck
Journal:  Obes Surg       Date:  2008-06-19       Impact factor: 4.129

6.  Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism.

Authors:  Devadoss J Samuvel; Kamala P Sundararaj; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

7.  Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistance.

Authors:  Georg Schaller; Yoshimasa Aso; Gerit-Holger Schernthaner; Hans-Peter Kopp; Toshihiko Inukai; Stefan Kriwanek; Guntram Schernthaner
Journal:  Obes Surg       Date:  2008-05-02       Impact factor: 4.129

8.  Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects.

Authors:  Caroline M Apovian; Sherman Bigornia; Melanie Mott; Melissa R Meyers; Jagadish Ulloor; Manana Gagua; Marie McDonnell; Donald Hess; Lija Joseph; Noyan Gokce
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

9.  Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese rats.

Authors:  Xiaoke Wang; Mengjie Cheng; Min Zhao; Aiguo Ge; Fangfang Guo; Min Zhang; Yanhong Yang; Liegang Liu; Nianhong Yang
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

Review 10.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.